Sophie Jones

Sophie Jones

Auto-generated profile, based on publicly available information

Sophie Jones

Centers for Disease Control and Prevention

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2019 in Malaria Journal
Verified
Journal Article
Open access
PDF file
JCJane Cunningham
Jane Cunningham
SJSophie Jones
Sophie Jones
MGMichelle L. Gatton
Michelle L. Gatton
JBJohn W. Barnwell
John W. Barnwell
QCQin Cheng
Qin Cheng
DBDavid Bell
David Bell
Malaria rapid diagnostic tests (RDTs) emerged in the early 1990s into largely unregulated markets, and uncertain field performance was a major concern for the acceptance of tests for malaria case management. This, combined with the need to guide procurement decisions of UN agencies and WHO Member States, led to the creation of an independent, internationally coordinated RDT evaluation programme aiming to provide comparative performance data of commercially available RDTs. Products were assessed against Plasmodium falciparum and Plasmodium vivax samples diluted to two densities, along with malaria-negative samples from healthy individuals, and from people with immunological abnormalities or non-malarial infections. Three measures were established as indicators of performance, (i) panel detection score (PDS) determined against low density panels prepared from P. falciparum and P. vivax wild-type samples, (ii) false positive rate, and (iii) invalid rate, and minimum criteria defined. Over eight rounds of the programme, 332 products were tested. Between Rounds 1 and 8, substantial improvements were seen in all performance measures. The number of products meeting all criteria increased from 26.8% (11/41) in Round 1, to 79.4% (27/34) in Round 8. While products submitted to further evaluation rounds under compulsory re-testing did not show improvement, those voluntarily resubmitted showed significant increases in P. falciparum (p = 0.002) and P. vivax PDS (p < 0.001), with more products meeting the criteria upon re-testing. Through this programme, the differentiation of products based on comparative performance, combined with policy changes has been influential in the acceptance of malaria RDTs as a case-management tool, enabling a policy of parasite-based diagnosis prior to treatment. Publication of product testing results has produced a transparent market allowing users and procurers to clearly identify appropriate products for their situation, and could form a model for introduction of other, broad-scale diagnostics.

23 July 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SJSophie Jones
Sophie Jones
GSGireesh Subramaniam
Gireesh Subramaniam
MPMateusz M. Plucinski
Mateusz M. Plucinski
DPDhruviben Patel
Dhruviben Patel
JPJasmine Padilla
Jasmine Padilla
ETEldin Talundzic
Eldin Talundzic
Histidine-rich protein 2 (HRP2) detecting rapid diagnostic tests (RDTs) have played an important role in enabling prompt malaria diagnosis in remote locations. However, emergence of pfhrp2 deleted parasites is threatening the efficacy of RDTs, and the World Health Organization (WHO) has highlighted surveillance of these deletions as a priority. Nested PCR is used to confirm pfhrp2 deletion but is costly and laborious. Due to spurious amplification of paralogue pfhrp3, the identity of nested exon 1 PCR product must be confirmed by sequencing. Here we describe a new one-step PCR method for detection of pfhrp2. To determine sensitivity and specificity, all PCRs were performed in triplicate. Using photo-induced electron transfer (PET) PCR detecting 18srRNA as true positive, one-step had comparable sensitivity of 95.0% (88.7–98.4%) to nested exon 1, 99.0% (94.6–99.9%) and nested exon 2, 98.0% (93.0–99.8%), and comparable specificity 93.8% (69.8–99.8%) to nested exon 1 100.0% (79.4–100.0%) and nested exon 2, 100.0% (74.4–100.0%). Sequencing revealed that one step PCR does not amplify pfhrp3. Logistic regression models applied to measure the 95% level of detection of the one-step PCR in clinical isolates provided estimates of 133p/μL (95% confidence interval (CI): 3-793p/μL) for whole blood (WB) samples and 385p/μL (95% CI: 31–2133 p/μL) for dried blood spots (DBSs). When considering protocol attributes, the one-step PCR is less expensive, faster and more suitable for high throughput. In summary, we have developed a more accurate PCR method that may be ideal for the application of the WHO protocol for investigating pfhrp2 deletions in symptomatic individuals presenting to health care facilities.

24 March 2025 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
SJSophie Jones
Sophie Jones
RSRichard Stanton
Richard Stanton
MDMarisa D’ANgeli
Marisa D’ANgeli
ABAudrey Brezak
Audrey Brezak
JSJenna Sinkevitch
Jenna Sinkevitch
MWMaroya Spalding Walters
Maroya Spalding Walters
In the United States, New Delhi metallo-beta-lactamase (NDM)-producing carbapenem-resistant Enterobacterales (CRE) are frequently associated with healthcare encounters. From September 2021 to September 2022, 21 patients with NDM-CRE identified from urine and without healthcare exposure were reported to the Centers for Disease Control and Prevention. Isolates were genetically similar to healthcare-associated strains.

18 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
CBCatherine Bakari
Catherine Bakari
SJSophie Jones
Sophie Jones
GSGireesh Subramaniam
Gireesh Subramaniam
CMCeline Isaack Mandara
Celine Isaack Mandara
MCMercy G Chiduo
Mercy G Chiduo
DIDeus Simon Ishengoma
Deus Simon Ishengoma
Background: Despite recent reports of false negative results among histidine-rich protein 2 (HRP2) based-malaria rapid diagnostic tests (mRDTs) caused by pfhrp2/3 gene deletions in different countries, there is paucity of data in Tanzania. Methods: This study assessed the status of pfhrp2/3 deletions in 7,543 blood sample using laboratory multiplex antigen detection (Plasmodium lactate dehydrogenase - pLDH, aldolase, and HRP2). Samples showing mRDT false negativity or aberrant relationship of HRP2 to pan-Plasmodium antigens were genotyped for pfhrp2/3 genes. Results: Of all samples, 2,417 (32.0%) were positive for any Plasmodium antigens while 5,126 (68.0%) were negative. About 99.8% (n=2,411) of antigen positive samples had HRP2, but 6 (0.2%) had only pLDH and/or pAldolase. Thirteen samples had atypical relationships between pan-Plasmodium antigens and HRP2, but were positive by PCR. An additional 16 samples with negative HRP2 mRDTs but positive by microscopy were also chosen; all giving 35 samples genotyped for pfhrp2/3. Of 35 samples, 4 (11.4%) failed to consistently amplify positive control genes (pfmsp1 and pfmsp2), and pfhrp2 and pfhrp3 genes were successfully amplified in 31 (88.6%) samples. Conclusions: Lack of pfhrp2 and/or pfhrp3 genes deletions in Plasmodium falciparum parasites supports continued use of HRP2-based mRDTs for routine malaria diagnosis in Tanzania.

23 October 2026 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
KMKiara McNamara
Kiara McNamara
DSDipesh Solanky
Dipesh Solanky
SJSophie Jones
Sophie Jones
EOElizabeth Ohlsen
Elizabeth Ohlsen
JBJ. Bradford Bertumen
J. Bradford Bertumen
JSJane D. Siegel
Jane D. Siegel
Objective: To investigate and halt transmission of Burkholderia multivorans at hospitals reporting B. multivorans outbreaks in California between September 2020 and February 2023. Methods: Case-patients were defined as adults without cystic fibrosis with B. multivorans isolated from any specimen source collected while an inpatient at an affected facility from January 2020 through February 2023 and confirmed as the outbreak strain by random amplified polymorphic DNA testing and repetitive extragenic palindromic polymerase chain reaction. We reviewed medical records to describe case-patients and identify common exposures; observations and staff interviews were completed to detect exposures to non-sterile water. Environmental samples and commercial products were tested for presence of B. multivorans. All B. multivorans isolates underwent whole genome sequencing. Results: We identified 25 case-patients. Most case-patients (n = 22, 88%) were hospitalized at the same hospital and received care in an intensive care unit (n = 17, 68%). Healthcare personnel reported using water and ice from ice machines for patient bathing, swallow evaluations, and pain relief. B. multivorans was identified from two ice machines at the hospital with the most case-patients in March 2022 and July 2022. All hospitals used the same brand of ice machine, filters, descaling, and sanitizing products. Clinical and ice machine B. multivorans isolates matched the outbreak strain. Conclusions: The use of water and ice from contaminated ice machines likely contributed to this outbreak. Ice machines can serve as reservoirs for Burkholderia spp. and should be investigated as sources of transmission during outbreaks of water-associated organisms in healthcare settings.